Friends and colleagues, we hope you will enjoy this inspiring story of innovation and collaboration that is helping keep our frontline healthcare professionals safe during this time of desperate need. “I saw nothing better I could do to give back to people like my mom, my dad — who have been working in emergency services…
The design and development process can make or break a medical device’s commercial potential. It is dependent on careful consideration of several intersecting aspects: technological, clinical, commercial and legal. Too many promising medtech innovations and early stage companies fail unnecessarily because they run out of funding before achieving milestones required for next-round investments. Medical device…
Medtech innovation is an exciting, yet risky enterprise. The vast majority of venture capital and strategic investors now want to see early investment in de-risking medical innovations. There is simply too much potential for failure in the pathway to commercialization, plus financial risk related to market forces and competitive products. Too many medtech development…
In mid-March 2020, the shortage of personal protective equipment for healthcare providers responding to the COVID-19 outbreak had become a national emergency. By the time the University System of Georgia suspended on-campus instruction and asked students to depart campus by March 13 in response to rapidly increasing numbers of COVID-19 cases, Christopher Saldana, Ph.D., associate…
Preclinical work, especially GLP studies, are costly and critical to the product’s successful regulatory submission. Efficiency and quality in preclinical work begins with a robust preclinical study protocol. Preclinical protocols are the foundation on which reports required by regulatory bodies are built. What elements in a preclinical study protocol give the study the best…
Aflac Incorporated, a leader in supplemental insurance at U.S. worksites, today announced it has contributed $5 million to two organizations that are providing assistance for health care workers on the front lines of the COVID-19 global pandemic. The $5 million donation includes: $2 million for the Global Center for Medical Innovation (GCMI), a comprehensive innovation center using innovative 3D printing to help…
In one week, a team of students in a joint biotech medical lab with Georgia Tech and Emory students started making and distributing face shields to help save lives. “The goal is to meet the needs locally to actually supply the Georgia Department of Public Health and when they have enough to actually supply…
From the Delta News Hub: April 2, 2020: Delta Flight Products, the airline’s wholly owned subsidiary, is collaborating with Global Center for Medical Innovation (GCMI), a non-profit affiliate of the Georgia Institute of Technology, to manufacture face shields to protect hospital workers during the COVID-19 pandemic. Using materials and designs provided by GCMI, Delta Flight…
“In response to the unprecedented challenges from the COVID-19 pandemic, ExxonMobil is applying its deep knowledge and experience with polymer-based technologies in combination with GCMI to facilitate development and expedite third-party production of innovative safety equipment that can be sterilized and worn multiple times. “A new industrial-style mask is being fast-tracked for production. The…
To our GCMI clients, experts, and friends – From the beginning of the COVID-19 crisis, my team and I have been focused on how GCMI can lend a hand. Today, I am asking you to help us accelerate our efforts. We are on the frontline of the COVID-19 relief effort. We are part of a…